Khiron Life Sciences KHRNF Stock
Khiron Life Sciences Price Chart
Khiron Life Sciences KHRNF Financial and Trading Overview
| Khiron Life Sciences stock price | 0.0080 USD |
| Previous Close | 0.02 USD |
| Open | 0.03 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.02 - 0.03 USD |
| 52 Week Range | 0.01 - 0.13 USD |
| Volume | 149.04K USD |
| Avg. Volume | 249.03K USD |
| Market Cap | 6.97M USD |
| Beta (5Y Monthly) | 3.155844 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
KHRNF Valuation Measures
| Enterprise Value | 5.73M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.43212405 |
| Price/Book (mrq) | 0.1888 |
| Enterprise Value/Revenue | 0.355 |
| Enterprise Value/EBITDA | -0.349 |
Trading Information
Khiron Life Sciences Stock Price History
| Beta (5Y Monthly) | 3.155844 |
| 52-Week Change | -72.093% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.13 USD |
| 52 Week Low | 0.01 USD |
| 50-Day Moving Average | 0.03 USD |
| 200-Day Moving Average | 0.06 USD |
KHRNF Share Statistics
| Avg. Volume (3 month) | 249.03K USD |
| Avg. Daily Volume (10-Days) | 145.57K USD |
| Shares Outstanding | 232.41M |
| Float | 206.03M |
| Short Ratio | N/A |
| % Held by Insiders | 4.64% |
| % Held by Institutions | 0.21% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2021 |
| Most Recent Quarter (mrq) | September 30, 2022 |
| Next Fiscal Year End | December 31, 2022 |
Profitability
| Profit Margin | -190.0039% |
| Operating Margin (ttm) | -108.068% |
| Gross Margin | 41.33% |
| EBITDA Margin | -101.66% |
Management Effectiveness
| Return on Assets (ttm) | -20.78% |
| Return on Equity (ttm) | -74.68% |
Income Statement
| Revenue (ttm) | 16.14M USD |
| Revenue Per Share (ttm) | 0.09 USD |
| Quarterly Revenue Growth (yoy) | -3.79% |
| Gross Profit (ttm) | 6.37M USD |
| EBITDA | -16406023 USD |
| Net Income Avi to Common (ttm) | -30661000 USD |
| Diluted EPS (ttm) | -0.11 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.94M USD |
| Total Cash Per Share (mrq) | 0.009 USD |
| Total Debt (mrq) | 2.56M USD |
| Total Debt/Equity (mrq) | 9.46 USD |
| Current Ratio (mrq) | 2.022 |
| Book Value Per Share (mrq) | 0.125 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -15012000 USD |
| Levered Free Cash Flow (ttm) | -8833852 USD |
Profile of Khiron Life Sciences
| Country | United States |
| State | BC |
| City | Vancouver |
| Address | 500 Burrard Street |
| ZIP | V6C 2B5 |
| Phone | N/A |
| Website | https://khiron.ca |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. It operates through Health Services, Medical Cannabis Products, and Wellbeing Products segments. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and cannabidiol (CBD) medical cannabis. It also operates a network of health centers and satellite clinics under the ILANS and Zerenia brands; develops CBD-based cosmeceutical products under the Kuida brand name; and operates Zerenia clinic in Medellin and Peru. Khiron Life Sciences Corp. was incorporated in 2012 and is headquartered in Vancouver, Canada.
Q&A For Khiron Life Sciences Stock
What is a current KHRNF stock price?
Khiron Life Sciences KHRNF stock price today per share is 0.0080 USD.
How to purchase Khiron Life Sciences stock?
You can buy KHRNF shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Khiron Life Sciences?
The stock symbol or ticker of Khiron Life Sciences is KHRNF.
Which industry does the Khiron Life Sciences company belong to?
The Khiron Life Sciences industry is Drug Manufacturers-Specialty & Generic.
How many shares does Khiron Life Sciences have in circulation?
The max supply of Khiron Life Sciences shares is 700.54B.
What is Khiron Life Sciences Price to Earnings Ratio (PE Ratio)?
Khiron Life Sciences PE Ratio is now.
What was Khiron Life Sciences earnings per share over the trailing 12 months (TTM)?
Khiron Life Sciences EPS is -0.01 USD over the trailing 12 months.
Which sector does the Khiron Life Sciences company belong to?
The Khiron Life Sciences sector is Healthcare.